Rating History for Antares Pharma (ATRS) by Ladenburg Thalmann

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/14/2022 Matthew Kaplan Downgrade Neutral
(Buy)
N/A
(N/A)
5.58
(5.59)
0.18% Details